MANTOVANI, GIOVANNA
MANTOVANI, GIOVANNA
Dipartimento di Scienze Cliniche e di Comunità
Preclinical evaluation of the antitumoral efficacy of Wee1 inhibitor AZD1775 in adrenocortical carcinoma
2025 E. Nozza, E. Emanuela, G. Di Muro, S. Di Bari, R. Catalano, G. Lopez, V. Vaira, A.M. Barbieri, G. Marra, M. Federica, T. Donatella, M. Battistin, Di Dalmazi Guido, S. Palmieri, F. Emanuele, G. Mantovani, E.M. Peverelli
AZD1775: effect of monotherapy or EDP-M combination in the treatment of ACC preclinical models
2025 E. Nozza, R. Catalano, G. Di Muro, S. Di Bari, G. Lopez, G. Marra, E. Esposito, F. Mangili, D. Treppiedi, M. Battistin, G. Mantovani, E. Peverelli
Potential antitumoral effects of SRPK1 inhibition through modulation of VEGF splicing in pituitary somatotroph tumoral cells
2025 D. Treppiedi, S. Di Bari, F. Mangili, A.M. Barbieri, G. Di Muro, M. Locatelli, A. Mangone, E. Peverelli, G. Mantovani
Reappraising prediction of surgical complexity of non-functioning pituitary adenomas after transsphenoidal surgery: the modified TRANSSPHER grade
2025 G. Fiore, G.A. Bertani, S.E. Baldeweg, A. Borg, G. Conte, N. Dorward, E. Ferrante, Z. Hussein, A. Miserocchi, K. Miszkiel, G. Mantovani, M. Locatelli, H.J. Marcus
Therapeutic potential of targeting the FLNA‐regulated Wee1 kinase in adrenocortical carcinomas
2025 E. Esposito, G. Marra, R. Catalano, S. Maioli, E. Nozza, A.M. Barbieri, C. Hantel, G. Di Dalmazi, S. Sigala, J. Geginat, E. Cassinotti, L. Baldari, S. Palmieri, A. Mangone, A. Berruti, E. Ferrante, G. Mantovani, E. Peverelli
La gestione terapeutica dell’ipoparatiroidismo: tra terapia convenzionale e nuove prospettive
2025 G. Del Sindaco, G. Mantovani
Who and how to screen for endogenous hypercortisolism in patients with mood disorders
2025 E. Ferrante, C. Simeoli, G. Mantovani, R. Pivonello
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas
2025 R. Catalano, E. Nozza, B. Altieri, E. Esposito, G.A. Croci, A.M. Barbieri, D. Treppiedi, S. Di Bari, O. Kimpel, M. Detomas, M. Tamburello, M.P. Schauer, S. Herterich, A. Angelousi, M. Luconi, L. Canu, G. Nesi, C. Hantel, S. Sigala, L. Landwehr, G. Di Dalmazi, E. Cassinotti, L. Baldari, S. Palmieri, A. Mangone, E. Ferrante, C.L. Ronchi, G. Mantovani, E. Peverelli
Recurrent hyponatremia due to syndrome of inappropriate antidiuresis after traumatic brain injury: two case reports
2025 I. Petria, R. Indirli, B. Mantovani, V. Lanzi, G. Mantovani, E. Ferrante
Identifying risk factors for pregnancy and lactation-associated osteoporosis: insights from an Italian survey in PLAO patients and controls
2025 G. Grassi, M. Zampogna, A. Atlasova, S. Rondinella, A. Ghielmetti, G. Siracusano, I. Chiodini, G. Mantovani, C. Eller-Vainicher
Skipping of Exon 20 in EP300: A Novel Variant Linked to Rubinstein-Taybi Syndrome With Atypical and Severe Clinical Manifestations
2025 L. Pavinato, S. Carestiato, S. Trajkova, L. Sorasio, G. Mantovani, L. De Sanctis, J. Kerkhof, H. Mcconkey, J. Rzasa, E. Todd, M. Balzo, S. Cardaropoli, A. Bruselles, S. De Rubeis, J.D. Buxbaum, M. Tartaglia, B. Sadikovic, G.B. Ferrero, A. Brusco
Sexual health in adult women with complete androgen insensitivity syndrome: a single centre cross-sectional study
2025 A. Mangone, E. Profka, G. Rodari, C. Giavoli, G. Mantovani
Germline-derived GNAS-Gsα variants associated with both gain-of-function and loss-of-function phenotypes
2025 A. Carcavilla, A. Pereda, M. Miyado, M. Fukami, F. Kato, T. Sengoku, K. Ogata, M. Clemente, I. Valenzuela, G. Mantovani, M. Cappa, P. Cavarzere, Y. Vado, I. González-Casado, T. Ogata, G. Perez De Nanclares
Neurofibromatosis type I (NF1) and bone involvement in a pediatric setting: insights from FGF23 levels
2025 G. Rodari, V. Citterio, M. Ikehata, D. Mattinzoli, G. Scuvera, F. Grilli, E. Profka, F. Giacchetti, V. Collini, A. Risio, C. Cesaretti, F. Natacci, C. Alfieri, G. Mantovani, C. Giavoli
Sequential Treatment for Osteoporosis After Teriparatide: A Real-Life Long-Term Comparison Between Zoledronic Acid and Denosumab
2025 A. Ghielmetti, G. Grassi, M. Zampogna, G. Mantovani, I. Chiodini, C. Eller-Vainicher
Adrenalectomy reduces the risk of vertebral fractures in patients with mild autonomous cortisol secretion
2025 V. Morelli, V. Favero, S. Frigerio, C. Aresta, F. Pugliese, A.S. Salcuni, A. Risio, C. Eller-Vainicher, S. Palmieri, E. Cairoli, S. Corbetta, G. Mantovani, A. Scillitani, I. Chiodini
Zoledronate after denosumab discontinuation: Is repeated administrations more effective than single infusion?
2024 G. Grassi, A. Ghielmetti, M. Zampogna, I. Chiodini, M. Arosio, G. Mantovani, C. Eller Vainicher
Inflammation-based scores in a large cohort of adrenocortical carcinoma and adrenocortical adenoma: role of the hormonal secretion pattern
2024 A. Mangone, V. Favero, A. Prete, Y.S. Elhassan, M. Asia, R. Hardy, G. Mantovani, I. Chiodini, C.L. Ronchi
Parathyroid carcinoma and atypical parathyroid tumor: analysis of an Italian database
2024 F. Marini, G. Marcucci, F. Giusti, E. Arvat, S. Benvenga, M. Bondanelli, L. Castellino, V. Camozzi, S. Corbetta, M.V. Davì, F. Famà, D. Ferone, M. Iacobone, P. Loli, G. Mantovani, U. Pagotto, L. Persani, G. Perigli, A. Piovesan, A. Repaci, R.M. Ruggeri, C. Eller-Vainicher, L. Vera, M.C. Zatelli, G. Zavatta, M.L. Brandi
Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas
2024 E. Esposito/, R. Catalano, E. Nozza, G. Marra, S. Maioli, G. Dimuro, A.M. Barbieri, H. Constanze, G. Didalmazi, J.E. Geginat, E. Cassinotti, L. Baldari, S. Palmieri, A. Mangone, E. Ferrante, G. Mantovani, E. Peverelli